INFLECTRA 100 MG VIAL

infliximab-dyyb
$491.5460per EA

Strength

100 mg/10mL

Manufacturer

Pfizer Inc.

NDC

00069080901

Classification

Brand Biologic

Dosage Form

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Route

INTRAVENOUS

Last Updated

3/19/2025

Active Ingredients

INFLIXIMAB

Approval Type

Biologic (BLA)

FDA Application

BLA125544

On Market Since

11/21/2016

Pharmacological Classes

Tumor Necrosis Factor Blocker
Tumor Necrosis Factor Receptor Blocking Activity

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

N/A

5Y

N/A

All

-14.9%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.